Trending Now
1
FDA Approves Amneal’s Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye
2
Presbyopia Drop Gets FDA New Drug Application Approval
3
Digital Screen Time Increases Risk for Myopia
4
Belite Bio Reports Positive Phase 3 Results of Tinlarebant in Adolescents With Stargardt Disease
5
Eyedrops to Change Iris Color Under Scrutiny
6
Lenz Announces Commercial Product Availability of Vizz in US
Conference Coverage
2025 Optometric Management Symposium
November 10, 2025
Updates in Nutrition and the Eye
November 10, 2025
Dry Eye Updates Highlight Diagnostic Precision and Tailored Care
American Academy of Optometry annual meeting
November 01, 2024
Life-threatening eye signs and symptoms to keep on your radar
November 01, 2024
Visual field defect testing can be life saving
November 01, 2024
Facilitating dry eye disease management
ASCRS 2025
April 27, 2025
Office-Based Therapies Gain Ground in Glaucoma Care
April 26, 2025
Cataract Surgery in Patients With Corneal Disease
April 27, 2025
How to Increase Volume in the Space You Have
Clinical Guidelines
View More
November 01, 2025
No-Fee CE: The Latest and Greatest in Soft Lenses
November 01, 2025
Does Solution Choice Impact Midday Fogging?
November 10, 2025
Dry Eye Updates Highlight Diagnostic Precision and Tailored Care
Commentary & Perspectives
View More
November 10, 2025
Understanding Myopia Management Options: Atropine
October 01, 2025
Thank You to the Readers of Ophthalmic Professional
February 01, 2020
LEADING OFF: Tips on How to Advise Patients to Retire From Driving
September 01, 2018
#DOMORE
FDA & Government News
View More
December 02, 2025
FDA Approves Amneal’s Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye
November 15, 2024
Eyenovia Halts Eye Drug Trial
April 24, 2025
FDA Rejects Extended Dosing Intervals for Eylea HD
May 09, 2025
West Virginia Gains Scope of Practice Expansion
Business Management
View More
January 01, 2021
Global Specialty Lens Symposium Review
May 01, 2021
Thought Leadership
June 01, 2018
BUSINESS: THE CEO CHECKLIST
March 01, 2020